Pharmagreen Biotech Inc. Net Income Loss

Quick Answer

Pharmagreen Biotech Inc. reported Net Income Loss of -$875.5 thousand for the year ending 2022.

  • Pharmagreen Biotech Inc. showed an increase of +80.7% in Net Income Loss from 2021 to 2022.
  • This data is from Pharmagreen Biotech Inc.'s annual report (Form 10-K), filed with the SEC on January 17, 2023.
  • XBRL data for this metric is available from 2018 to 2022 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2018 to 2022), Pharmagreen Biotech Inc.'s Net Income Loss has grown by 18.5%.
  • Historical annual values: Fiscal year 2022: -$875.5 thousand | Fiscal year 2021: -$4.53 million | Fiscal year 2020: -$2.48 million | Fiscal year 2019: -$767.5 thousand | Fiscal year 2018: -$1.07 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: